Clinic
Community Medical & Dental Care INC
Community Medical & Dental Care INC was paid $23.34M by Medicaid between Jan 2018 and Dec 2024, across 148 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoCOMMUNITY MEDICAL & DENTAL CARE INC
MONSEY, NY 10952
MONSEY, NY 10952
33aNPI1972681484assigned 11/01/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$23.34M
24GClaims518,322
24DCodes billed148
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New York
Rank by total paid#18 of 158
Median peer was paid$1.73M
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 60,775 | $3.60M | |
| 2019 | 67,806 | $3.82M | |
| 2020 | 119,289 | $5.02M | |
| 2021 | 131,429 | $5.15M | |
| 2022 | 59,715 | $2.88M | |
| 2023 | 54,531 | $1.84M | |
| 2024incomplete | 24,777 | $1.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 82,493 | 50,697 | $5.29M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 17% | 45,982 | 13,583 | $4.07M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.4% | 29,073 | 18,289 | $1.49M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.7% | 15,753 | 9,705 | $1.33M |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | 5.0% | 24,610 | 16,922 | $1.17M |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 2.8% | 8,615 | 5,897 | $658K |
| D1110 | Prophylaxis - adult | 2.8% | 14,364 | 12,943 | $656K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2.8% | 24,705 | 4,765 | $650K |
| D0140 | Limited oral evaluation - problem focused | 2.2% | 12,602 | 8,433 | $518K |
| 76830 | Ultrasound, transvaginal | 1.9% | 3,615 | 2,587 | $438K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.5% | 8,079 | 5,317 | $346K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.4% | 5,925 | 1,629 | $335K |
136 more codes
| 90785 | 1.4% | 24,180 | $331K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 1.3% | 4,539 | $295K |
| 90791 | Psychiatric diagnostic evaluation | 1.2% | 2,311 | $284K |
| D0220 | Intraoral - periapical first radiographic image | 1.1% | 20,502 | $257K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 5,986 | $257K |
| 99051 | 1.0% | 39,733 | $244K | |
| 90832 | Psychotherapy session, about 30 minutes | 1.0% | 3,205 | $242K |
| D9310 | <1% | 3,072 | $227K | |
| D0274 | Bitewings - four radiographic images | <1% | 9,527 | $222K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 2,224 | $215K |
| 59425 | <1% | 1,398 | $193K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 17,518 | $181K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,221 | $159K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,803 | $150K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,329 | $143K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,121 | $140K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,937 | $134K |
| D1120 | Dental cleaning, child | <1% | 3,755 | $133K |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 1,501 | $123K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,627 | $122K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,842 | $115K |
| D0330 | Panoramic radiographic image | <1% | 3,748 | $114K |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 1,376 | $111K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,163 | $110K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 1,154 | $104K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,496 | $101K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,014 | $98K |
| 99441 | <1% | 3,411 | $95K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 2,013 | $93K |
| D1351 | Sealant - per tooth | <1% | 804 | $79K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 753 | $79K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,238 | $68K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 4,357 | $63K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,777 | $61K |
| 90837 | Psychotherapy session, about an hour | <1% | 552 | $57K |
| D9110 | <1% | 1,152 | $56K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 612 | $48K |
| 59426 | <1% | 357 | $47K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,051 | $44K |
| D2331 | <1% | 532 | $43K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 4,371 | $42K |
| G0467 | Community health center visit, returning patient | <1% | 2,634 | $39K |
| D0272 | Bitewings - two radiographic images | <1% | 2,535 | $36K |
| 81002 | <1% | 4,862 | $33K | |
| D2750 | <1% | 82 | $30K | |
| D5899 | <1% | 238 | $29K | |
| D2954 | <1% | 237 | $27K | |
| 92552 | <1% | 3,575 | $26K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 1,235 | $25K |
| S9442 | Birthing classes, non-physician provider, per session | <1% | 312 | $22K |
| 99443 | <1% | 183 | $22K | |
| 87428 | <1% | 319 | $22K | |
| 99442 | <1% | 333 | $19K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 108 | $18K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 1,089 | $17K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 219 | $15K |
| D2999 | <1% | 149 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,857 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,171 | $14K |
| 95117 | <1% | 283 | $14K | |
| D2330 | <1% | 180 | $14K | |
| D0270 | <1% | 1,250 | $14K | |
| D4341 | <1% | 133 | $14K | |
| D2140 | <1% | 188 | $13K | |
| 99205 | Prolong outpt/office vis | <1% | 83 | $13K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 81 | $12K |
| 99201 | <1% | 129 | $10K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 32 | $9K |
| 82962 | <1% | 1,086 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,120 | $8K |
| 11721 | <1% | 221 | $8K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 82 | $8K |
| 0002A | <1% | 199 | $8K | |
| 0001A | <1% | 210 | $8K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 286 | $7K |
| D0160 | <1% | 116 | $7K | |
| 69210 | <1% | 156 | $7K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,066 | $7K |
| D3320 | <1% | 33 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 18 | $7K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 74 | $6K |
| 90674 | <1% | 168 | $5K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 17 | $5K |
| 87430 | <1% | 1,226 | $5K | |
| 90461 | <1% | 1,478 | $4K | |
| 97166 | <1% | 50 | $4K | |
| 90658 | <1% | 149 | $4K | |
| 96150 | <1% | 441 | $4K | |
| 0012A | <1% | 98 | $4K | |
| 0011A | <1% | 100 | $3K | |
| 96127 | <1% | 1,941 | $3K | |
| 0031A | <1% | 70 | $3K | |
| 81025 | <1% | 556 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 630 | $2K |
| 92015 | Determination of refractive state | <1% | 77 | $2K |
| 92225 | <1% | 59 | $2K | |
| 90756 | <1% | 134 | $2K | |
| 97802 | <1% | 1,392 | $2K | |
| 97167 | <1% | 39 | $2K | |
| 0071A | <1% | 33 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 42 | $1K |
| 11056 | <1% | 12 | $967.89 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 548 | $848.03 |
| 90707 | <1% | 25 | $840.03 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 79 | $832.66 |
| 93000 | <1% | 53 | $796.33 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 189 | $692.45 |
| 0064A | <1% | 16 | $602.45 | |
| 90688 | <1% | 30 | $566.88 | |
| 0004A | <1% | 14 | $520.64 | |
| 90686 | <1% | 744 | $516.77 | |
| 96160 | <1% | 140 | $488.67 | |
| 98960 | <1% | 422 | $470.05 | |
| 99173 | <1% | 115 | $403.18 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 34 | $340.89 |
| 90734 | <1% | 106 | $322.95 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 27 | $320.87 |
| 90651 | <1% | 14 | $245.69 | |
| 86580 | <1% | 27 | $149.13 | |
| 92558 | <1% | 138 | $114.81 | |
| 90670 | <1% | 472 | $79.32 | |
| 99177 | <1% | 220 | $78.72 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 56 | $60.14 |
| 90723 | <1% | 259 | $50.01 | |
| 99401 | <1% | 13 | $47.85 | |
| 99172 | <1% | 151 | $14.37 | |
| 99072 | <1% | 6,733 | $0.14 | |
| 90648 | <1% | 322 | $0.02 | |
| 90633 | <1% | 37 | $0.01 | |
| 36410 | 0% | 37 | $0.00 | |
| 99000 | 0% | 188 | $0.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 22 | $0.00 |
| 90680 | 0% | 25 | $0.00 | |
| 90710 | 0% | 52 | $0.00 | |
| 90715 | 0% | 47 | $0.00 | |
| 90713 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOFFMAN, MENDEL (PRESIDENT CEO)